Authors:
KELLEHER AD
ROGGENSACK M
JARAMILLO AB
SMITH DE
WALKER A
GOW I
MCMURCHIE M
HARRIS J
PATOU G
COOPER DA
Citation: Ad. Kelleher et al., SAFETY AND IMMUNOGENICITY OF A CANDIDATE THERAPEUTIC VACCINE, P24 VIRUS-LIKE PARTICLE, COMBINED WITH ZIDOVUDINE, IN ASYMPTOMATIC SUBJECTS, AIDS, 12(2), 1998, pp. 175-182
Authors:
KLEIN MR
VEENSTRA J
HOLWERDA AM
ROOS MTL
GOW I
PATOU G
COUTINHO RA
DEWOLF F
MIEDEMA F
Citation: Mr. Klein et al., GAG-SPECIFIC IMMUNE-RESPONSES AFTER IMMUNIZATION WITH P17 P24-TY VIRUS-LIKE PARTICLES IN HIV TYPE 1-SEROPOSITIVE INDIVIDUALS/, AIDS research and human retroviruses, 13(5), 1997, pp. 393-399
Authors:
PETERS BS
CHEINGSONGPOPOV R
CALLOW D
FOXALL R
PATOU G
HODGKIN K
WEBER JN
Citation: Bs. Peters et al., A PILOT PHASE-II STUDY OF THE SAFETY AND IMMUNOGENICITY OF HIV P17 P24-VLP (P24-VLP) IN ASYMPTOMATIC HIV-SEROPOSITIVE SUBJECTS/, The Journal of infection, 35(3), 1997, pp. 231-235
Authors:
SMITH DE
BOAG F
COLEBUNDERS R
WELLER IVD
TCHAMOUROFF S
WEBER J
GOW I
PATOU G
COOPER DA
Citation: De. Smith et al., THERAPEUTIC VACCINATION (P24-VLP) OF PATIENTS WITH ADVANCED HIV-1 INFECTION DOES NOT ALTER CD4 DECLINE, AIDS, 10, 1996, pp. 65-65
Authors:
KELLEHER AD
SMITH DE
COOPER DA
WALKER A
GOW I
PATOU G
Citation: Ad. Kelleher et al., EFFECT OF THERAPEUTIC VACCINATION (P24-VLP) AND AZT ON IMMUNOLOGICAL MARKERS IN EARLY HIV DISEASE, AIDS, 10, 1996, pp. 137-137
Authors:
VEENSTRA J
WILLIAMS TG
COLEBUNDERS R
DORRELL L
TCHAMOUROFF SE
PATOU G
LANGE JMA
WELLER IVD
GOEMAN J
UTHAYAKUMAR S
GOW IR
WEBER JN
COUTINHO RA
Citation: J. Veenstra et al., IMMUNIZATION WITH RECOMBINANT P17 P24-TY VIRUS-LIKE PARTICLES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS/, The Journal of infectious diseases, 174(4), 1996, pp. 862-866
Authors:
WEBER J
CHEINSONGPOPOV R
CALLOW D
ADAMS S
PATOU G
HODGKIN K
MARTIN S
Citation: J. Weber et al., IMMUNOGENICITY OF THE YEAST RECOMBINANT P17 P242-TY VIRUS-LIKE PARTICLES (P24-VLP) IN HEALTHY-VOLUNTEERS/, Vaccine, 13(9), 1995, pp. 831-834